In Brief
This article was originally published in The Tan Sheet
Executive Summary
Nestle, Chi-Med team up to develop nutritional drug products; FDA keeps lindane lice products available; contract manufacturer draws GMP warning, FDA reminds Health Technology; Sensa marketer settles false advertising suit; FDA suspends Sunland peanut facility.
You may also be interested in...
Regulatory News In Brief
Peanut recalls spread to nutrition bars; Maxam missing supplement manufacturing specs; Amazing Herbs slip on GMPs; FDA finds hygiene errors in Creation’s Garden; Avon, Bioque cosmetics make drug claims; more Regulatory News In Brief.
Lindane Ban Request Presents Chance To Promote Natural Lice Solutions
The insecticide agent lindane used in lice treatments is hazardous, ineffective and bad for the environment, Rep. Markey says in a letter to FDA. Growing criticism of the use of harsh chemicals could create opportunities for natural solutions to grow sales.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.